Fresenius Medical Care Q1 Results Down; Confirms FY21 Outlook
Basic earnings per share decreased 10 percent to 0.85 euro from 0.95 euro a year ago.
Operating income fell 15 percent to 474 million euros from last year s 555 million euros. Operating margin was 11.3 percent, down from 12.4 percent a year ago.
Revenue declined 6 percent to 4.21 billion euros from prior year s 4.49 billion euros. Revenues grew 1 percent at constant currency. Organic growth amounted to 1 percent.
Further, the company confirmed fiscal 2021 financial targets stating that the underlying development in the first three months was in line with expectations.
The Company continues to expect revenue to grow at a low- to mid-single digit percentage rate and net income to decline at a high-teens to mid-twenties percentage rate against the 2020 base.
Share this article
Share this article
USD 8.03 billion by 2028 according to a new study conducted by
Polaris Market Research. the market is anticipated to register a
CAGR of
7.4%
from 2021 – 2028 Technological advancements in the development of medical devices coupled with a rise in the number of surgeries conducted across the globe requiring the use of advanced medical devices are making a higher impact on the market growth. In addition to this, increasing cases of blood transfusions, especially in major developed countries, and growing patient s need for central venous access during long-term intravenous therapy such as chemotherapy and antimicrobial therapy is further fostering the market growth. Furthermore, a rise in government spending for the improvement of healthcare infrastructure is expected to support market development in the longer run.
European Markets Close Higher On Earnings, Recovery Hopes
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European markets closed higher on Wednesday, reacting positively to some upbeat earnings reports and encouraging economic data that indicate a fairly strong global economic rebound.
Mining stocks moved higher as copper prices rose past a key psychological level of $10,000 a ton, supported by prospects for higher demand. Energy stocks gained in strength, as crude oil prices surged higher on expectations of increased demand for oil.
Investors were also looking ahead to Bank of England s monetary policy, due on Thursday.
Data from Eurostat showed Eurozone private sector growth continued for second consecutive month as manufacturing and services industries expanded. The IHS Markit composite purchasing managers index rose to 53.8 in April from 53.2 in March. That was slightly stronger than a preliminary reading of 53.7.
hirenMay 4, 2021
Elective Healthcare Services Market. The
Global Elective Healthcare Services Market Research Report Covers, Future Trends, Size, Share, Past, Present Data and Deep Analysis, And Forecast, 2021-2027. To calculate the market size, the report considers revenue generated from the sales of products under the scope of the report. The report also considers the revenues to be generated from the sales of the product, which is expected to be launched into the market during the forecast period. This well-drafted report involves the current market status, historical data, and prediction outlook.
The top Major Competitive Players are :
Fortis Healthcare, Tata Memorial Hospital, Apollo Hospital, Shanghai Redleaf International Women’s & Children’s Hospital, IHH Healthcare Berhad, Luye Medical Group, Capio AB, Moorfields Eye Hospital, Ramsay Générale de Santé, PillPack, Guizhou Ensure Chain Pharmacy Company Limited, and Fresenius Medical Care.
Share:
New York, May 04, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Vascular Access Device Market Research Report by Product, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p05911840/?utm source=GNW
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Vascular Access Device Market is expected to grow from USD 4,264.78 Million in 2020 to USD 5,945.85 Million by the end of 2025.